About Biotech Patents
The aim of a biotech company is – no surprise - to
own strong patents, and to
work in a field that is not infringing third party claims. It is thus key to establish a
patent portfolio of proprietary rights with an eye to third party patent claims, i.e.
avoid patent conflicts early on or to obtain the respective licenses as needed.
There are a few specifics to consider when dealing with biotech patents and
intellectual property (IP).
IP plays a core role in all biotechnology companies; many early stage companies
have few other assets and depend on strong IP to attract investment or partners.
Investors are thus increasingly assessing the strength of IP portfolios in order to
reduce the exposure to risk. Therefore, IP due diligence is considered a key driver
of funding and deal making.